PMVP · PMV Pharmaceuticals, Inc.
$1.22
-0.02 (-1.61%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the Company's current available cash, cash equivalents and marketable securities may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$65.49M
Shares
53.46M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-14 | — | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-22 | 2026-06-04 | |
| 8-K | 2026-03-06 | — | |
| 10-K | 2026-03-06 | 2025-12-31 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-09 | 2025-06-05 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-25 | 2025-06-05 | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-08 | 2024-08-05 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-06 | |
| 8-K | 2024-02-29 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-01-18 | — | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-12 | — | |
| 8-K | 2023-10-11 | — | |
| 8-K | 2023-08-09 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-06-09 | 2023-06-08 | |
| 8-K | 2023-05-10 | — | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-08 | |
| 8-K | 2023-04-28 | 2023-04-24 | |
| 10-K | 2023-03-01 | 2022-12-31 | |
| 8-K | 2023-03-01 | — | |
| 10-Q | 2022-11-08 | 2022-09-30 | |
| 8-K | 2022-11-08 | — | |
| 8-K | 2022-11-04 | 2022-11-03 | |
| 8-K | 2022-08-09 | — | |
| 10-Q | 2022-08-09 | 2022-06-30 | |
| 8-K | 2022-06-08 | 2022-06-07 |
Showing 1–50 of 73 filings
Key facts
CIK
1699382
CUSIP
69353Y103
13F (30d)
63 filings
63 filers
Visit website
Investor relations